Combined Monitoring and Analysis Relieve Staff and Patients Alike
|
By HospiMedica International staff writers Posted on 28 Feb 2013 |
|
Image: The Infinity Gateway Suite is a comprehensive set of applications, developers’ tools, and interfaces that facilitate the exchange of patient information between the Infinity Network and existing hospital systems (Photo courtesy of Dräger Medical).
A technological cooperation is capable of fully automatic capture and analysis of recorded real time electrocardiogram (ECG) data, without additional effort for the clinical staff.
The combined capabilities of the Infinity monitoring system, a product of Dräger Medical (Lübeck, Germany) and the Stroke Risk Analyzer (SRA) clinic system, developed by apoplex medical technologies (Pirmasens, Germany), are intended to assist in the rapid risk analysis ECG data to for paroxysmal atrial fibrillation (pxAF). The Infinity monitoring system gateway records the multichannel ECG and automatically and transfers it as a data packet to the SRAclinic analysis server.
After the analysis of the patient´s ECG data by SRAclinic, the treating physician receives a report within the first therapy hours, which provides information about the individual risk for pxAF and indications regarding acute atrial fibrillation (AF). The report can then help guide in making therapy decisions. Until now, a separate Holter recorder was used to measure long term ECG, which had to be applied to the patient by the clinical staff using electrodes, and needed to be disconnected after recording up to three days of ECG data of. The recorded data were than analyzed following a time delay.
“We are happy having achieved a breakthrough in the detection of paroxysmal atrial fibrillation with our cooperation, and to provide the treating physicians with a unique, fast, easy and clinically validated analysis tool,” said Albert Hirtz, managing director of apoplex medical technologies.
“Unique in our combination is that the ECG data are transferred to SRAclinic without any interaction of the clinical staff,” added Herbert Schmidt, marketing manager of monitoring and IT-systems at Dräger Medical.
AF is often first detected clinically by auscultation by a health care provider; the diagnosis is then confirmed with an ECG. To confirm this diagnosis, patients may wear a portable Holter monitor for continuous ECG recording, since pxAF, episodes occur intermittently, and may only last a few seconds or minutes. pxAF is one of the most frequent causes for stroke, and even after a stroke may sometimes evade detection, and hence is untreated; as a result, the risk for recurrent strokes remains.
Related Links:
Dräger Medical
apoplex medical technologies
The combined capabilities of the Infinity monitoring system, a product of Dräger Medical (Lübeck, Germany) and the Stroke Risk Analyzer (SRA) clinic system, developed by apoplex medical technologies (Pirmasens, Germany), are intended to assist in the rapid risk analysis ECG data to for paroxysmal atrial fibrillation (pxAF). The Infinity monitoring system gateway records the multichannel ECG and automatically and transfers it as a data packet to the SRAclinic analysis server.
After the analysis of the patient´s ECG data by SRAclinic, the treating physician receives a report within the first therapy hours, which provides information about the individual risk for pxAF and indications regarding acute atrial fibrillation (AF). The report can then help guide in making therapy decisions. Until now, a separate Holter recorder was used to measure long term ECG, which had to be applied to the patient by the clinical staff using electrodes, and needed to be disconnected after recording up to three days of ECG data of. The recorded data were than analyzed following a time delay.
“We are happy having achieved a breakthrough in the detection of paroxysmal atrial fibrillation with our cooperation, and to provide the treating physicians with a unique, fast, easy and clinically validated analysis tool,” said Albert Hirtz, managing director of apoplex medical technologies.
“Unique in our combination is that the ECG data are transferred to SRAclinic without any interaction of the clinical staff,” added Herbert Schmidt, marketing manager of monitoring and IT-systems at Dräger Medical.
AF is often first detected clinically by auscultation by a health care provider; the diagnosis is then confirmed with an ECG. To confirm this diagnosis, patients may wear a portable Holter monitor for continuous ECG recording, since pxAF, episodes occur intermittently, and may only last a few seconds or minutes. pxAF is one of the most frequent causes for stroke, and even after a stroke may sometimes evade detection, and hence is untreated; as a result, the risk for recurrent strokes remains.
Related Links:
Dräger Medical
apoplex medical technologies
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Rapid Sepsis Test
SeptiCyte RAPID
New
X-Ray Generator
Advantage Plus Generators
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
